Genetic Testing Services Market
Genetic Testing Services Market Analysis by Prenatal Testing, New Born Screening, Predictive & Presymptomatic Testing, and Pharmacogenomic Testing from 2023 to 2033
Analysis of Genetic Testing Services Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Genetic Testing Services Market Outlook (2023 to 2033)
Expanding at a CAGR of 8.5%, the global genetic testing services market size is predicted to increase from a valuation of US$ 3,956 million in 2023 to US$ 8,944.4 million by the end of 2033.
Global demand for newborn screening is projected to increase at a CAGR of 8.5% during the forecast period due to many infants being diagnosed with hyperthyroidism and other chronic disorders. Genetic tests are used to check for genetic illnesses in the human body. They come in the form of kits and panels. The chromosomes, genes, and proteins are examined as part of a medical procedure known as DNA testing.
The genetic conditions that determine any genetic disorder or disease in the patients can be suspected by genetic tests. Genetic testing aids in the diagnosis of illnesses, the severity of the disease, diagnosis to discover gene mutations, and the risk of getting the illnesses, and also enables the patient and the doctor to decide correct treatment.
The population now has the freedom to perform their own genetic testing because of technological advances. DNA testing kits may be ordered from websites such as Ancestry.com and 23andme.com and delivered right to the house. One can quickly upload the test results after getting them to websites that print out medical diagnoses and offer their analyses. As more people sign up for genetic testing online and learn more about their DNA, the business has been significantly impacted by the accessibility of genetic testing.
Without consulting their doctors, people can better understand their genetic information due to direct-to-consumer genetic testing. Consumer awareness of the connections between genetics and diseases, which supports the advancement of patients' health and precision medicine based on unique genetic profiles, is a primary driver of genetic testing services market growth.
Companies are working to enhance carrier status identification and customer usability for reliable genetic testing. Additionally, it can be anticipated that rising consumer use and subsequent follow-up with healthcare professionals and insurers will fuel the expansion of direct-to-consumer genetic testing.
Numerous R&D organizations are introducing novel methods for more precise disease diagnosis. The rise in crime rates and the critical role played by genetic testing in forensic investigations both contribute significantly to market growth.
Market expansion is supported by the rise in the frequency of chronic diseases and the local supply of advanced testing kits for specialized therapeutic fields. The increased emphasis placed on regulating genetic testing and raising public awareness about them by governments in various countries has successfully sped up their global adoption.
Report Attributes |
Details |
|
Genetic Testing Services Market Size in 2023 |
US$ 3,956 Million |
|
Projected Market Value (2033) |
US$ 8,944.4 Million |
|
Global Market Growth Rate (2023 to 2033) |
8.5% CAGR |
|
Market Share of New Born Screening |
60% |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Factors are Paving the Way for Genetic Testing Service Providers?
“Rising Worldwide Prevalence of Autoimmune Diseases”
Growing prevalence of autoimmune diseases is augmenting the demand for genetic testing services. Genetic testing services are widely used for many applications in the fields of oncology, obstetrics, and ancestry as well. These services are purported to assist clinicians and patients to identify hereditary factors leading to the outbreak of the diseases mentioned above.
These trends are expected to boost market growth over the coming years. Other generic factors, such as an increase in population and the prevalence of communicable and non-communicable diseases are also expected to boost genetic testing services market share.
“Surging Usage of Healthcare IT in Genetics”
Big data accumulation provides an opportunity to integrate and store important genetic information. The usage of healthcare IT aids in research and help take clinical decisions.
The emergence of new detection technologies in the genetic testing services market has enhanced the value of disease treatment. Manufacturers are focusing on developing techniques such as polymerase chain reaction, imaging, and microarrays with greater depth of interaction (DOI) information.
The concept of personalized medicine is that every patient is an individual who needs specialized pharmacological treatment. To increase the viability and usefulness of customized drugs for the diagnosis of diseases and disorders, large-scale drug development is required. Pharmacogenomics, often known as drug-gene testing, widely uses genetic testing. It helps in drug development and discovery.
Scientists are aware that a variety of genetic testing techniques, including cytogenetic, biochemical, molecular, and DNA sequencing, appear to provide customized disease treatments. Furthermore, it is anticipated that more patients would want genetic testing from primary care doctors, particularly healthy adults looking for early detection or prevention of hereditary disorders. This trend is anticipated to foster market expansion.
The emergence of novel testing kits as a result of new developments and the increased prevalence of genetic and chronic diseases are the two main factors driving the global genetic testing market. The demand for genetic testing services is being fueled by consumers' increasing awareness of the availability of advanced diagnostic procedures.
An increase in the geriatric population is anticipated to fuel market expansion over the coming years. Older adults have a high risk to develop a variety of chronic conditions, which may increase global demand for genetic testing.
How is Industry Growth Being Restrained to Some Extent?
“High Cost of Genetic Testing Equipment and Shortage of Skilled Professionals”
The social and ethical consequences of genetic testing and privacy & security issues with genetic data are the factors restraining market growth. The expansion of the global genetic testing services market for is constrained by strict regulatory conditions regarding the approval of new products and a shortage of skilled professionals who can analyze the data. Pricing trends show that the high cost of genetic testing equipment is hampering market expansion.
Why is North America Dominating the Market for Genetic Testing Services?
“Increased Need for Genetic Testing to Understand Ancestry”
North America is an attractive market for genetic testing services with 40% share. The increased need for genetic testing to understand ancestry and the rise in demand for pre-implantation testing and in-vitro fertilization (IVF) are some key drivers augmenting market share. The rapid adoption of new technologies, the introduction of novel diagnostic techniques, and the huge demand for cancer diagnostics are driving genetic testing services market growth in the region.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
What is the Market Outlook for Genetic Testing Services in the United States?
“Huge Demand for Personalized Genetic Testing Solutions in the Country”
Increasing prevalence of chronic and genetic disorders, huge demand for personalized genetic testing solutions, and high awareness of hereditary conditions are boosting market value in the United States. The genetic testing services market is projected to expand over the forecast period as a result of rising cancer incidences, proactive strategies adopted by major players, and government support for direct-to-consumer genetic testing.
How is Germany Driving Market Growth in Europe?
“Growing Awareness of Advantages of Genetic Testing among People”
Market expansion in Germany is accelerated by the introduction of reimbursement programs, surging demand for efficient treatment methods, and rapid implementation of advanced technologies in research centers. Growing awareness of the advantages of genetic testing among people and a rise in consumer spending on healthcare are the elements driving market growth in the country.
What’s Driving Genetic Testing Service Demand in Japan?
“Rapid Adoption of Modern Genomic Technologies”
Japan is set to be the most lucrative genetic testing services market, expected to register a robust CAGR of 8.4%.
Market growth in Japan is attributed to a rise in the geriatric population, the rapid adoption of modern genomic technologies, and the affordability of genetic testing. The market is driven by elements such as an increase in government funding for R&D, new developments in genetic testing technology, and growing awareness of the disease's early detection among individuals.
Category-wise Insights
Which Genetic Testing Ser Type vices Will Bring in High Revenue Streams?
“New Born Screening Supporting Identification of Infant Abnormalities or Syndromes”
Based on test type, the market is divided into prenatal testing, new born screening, predictive and presymptomatic testing, pharmacogenomic testing, and others. New born screening accounts for 60% share of the global market. New born screening aids in the identification of infant abnormalities or syndromes. For the early discovery, diagnosis, and intervention of an illness or disorder, new born screening is essential.
Infants are screened for particular diseases and abnormalities that can impair their ability to develop normally. Mental and physical problems as well as life-threatening illnesses can be avoided with early detection and treatment. Prenatal testing is done throughout pregnancy to find any birth defects in newborn babies.
Which Application is Likely to Contribute the Most to Market Expansion?
“Growing Awareness of Early Cancer Identification Driving Demand for Genetic Testing Services in Oncology”
Based on application, the market is classified into oncology, infectious diseases, autoimmune diseases, and others. The adoption of genetic testing services in oncology is increasing due to the growing prevalence of cancer and increasing awareness of early cancer identification among people.
Genetic testing enables the identification of an individual's lifetime risk for specific cancer forms. Inherited variations and mutations in the DNA sequence, which could cause uncontrollable cell development and result in tumors or cancer, can be tested via genetic tests.
Huge demand for genetic testing services in oncology is attributed to the rising public awareness of preventive diagnostics and personalized medicine. Oncology biomarkers can offer economical, trustworthy, precise, non-invasive, and sensitive data to help manage cancer successfully.
Genetic tests help in determining whether cancer runs in the family and the risk factors for cancer development in the future for people with a family history of the disease. Additionally, genetic testing is performed on individuals who do not react to chemotherapy to find out if tumors that are resistant to treatment have acquired mutations.
Competitive Landscape
Top genetic testing service providers are concentrating on improving product standards following safety regulations to lower the environmental impact. Major market participants are maintaining quality control to enhance genetic testing systems. Leading companies should focus on product innovation, R&D, form solid distribution partnerships, and supply chain management to maintain a competitive edge in the market.
For instance :
- In July 2021, Avellino Labs announced the release in the United States of AvaGen, the genetic eye test intended to assess a patient's risk of developing keratoconus and other corneal dystrophies. It is projected that these activities by significant industry participants will propel market expansion.
- Under the brand name Genessense, MedGenome Labs introduced its direct-to-consumer segment. Through the Genessense website or future e-Commerce platforms, it will provide specialized, research-based genetic screening tests that may be obtained online.
Genetic Testing Services Industry Research Segmentation
-
By Test Type :
- Prenatal Testing
- New Born Screening
- Predictive and Presymptomatic Testing
- Pharmacogenomic Testing
- Others
-
By Application :
- Oncology
- Infectious Diseases
- Autoimmune Diseases
- Others
-
By Service Provider :
- Hospital-based Laboratories
- Diagnostic Laboratories
- Specialty Clinics
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Assumptions and Acronyms Used 2.2. Research Methodology 3. Executive Summary 3.1. Global Market Size (US$ Mn) and Forecast, by Region, 2023 and 2033 3.2. Global Market: Market Snapshot 4. Market Overview 4.1. Global Market Overview 4.2. Global Market Key Industry Developments 4.3. Key Industry Events 5. Market Dynamics 5.1. Drivers and Restraints Snapshot Analysis 5.2. Drivers 5.3. Restraints 5.4. Opportunities 5.5. Key Trends 5.6. Global Market Revenue Projections (US$ Mn), 2023–2033 5.7. Market: Mergers & Acquisitions 5.8. Heat Map Analysis - Company 6. Global Market Analysis, by Test Type 6.1. Introduction 6.2. Key Insights 6.3. Global Market Size and Forecast, by Test Type 6.3.1. Prenatal Testing Services 6.3.2. New Born Screening 6.3.3. Predictive and Presymptomatic Testing 6.3.4. Pharmacogenomic Testing 6.3.5. Others 6.4. Global Market Analysis, by Test Type 6.5. Global Market Attractiveness Analysis, by Test Type 7. Global Market Analysis, by Service Providers 7.1. Introduction 7.2. Key Insights 7.3. Global Market Size and Forecast, by Service Providers 7.3.1. Hospital Based Laboratories 7.3.2. Diagnostic laboratories 7.3.3. Specialty Clinics 7.3.4. Others 7.4. Global Market Analysis, by Service Providers 7.5. Global Market Attractiveness Analysis, by Service Providers 8. Global Market Analysis, by Applications 8.1. Introduction 8.2. Key Insights 8.3. Global Market Size and Forecast, by Applications 8.3.1. Oncology 8.3.2. Infectious Diseases 8.3.3. Autoimmune Diseases 8.3.4. Others 8.4. Global Market Analysis, by Applications 8.5. Global Market Attractiveness Analysis, by Applications 9. Global Market Analysis, by Region 9.1. Introduction 9.2. Key Insights 9.3. Global Market Size and Forecast , by Region, 2023–2033 9.3.1. North America 9.3.2. Europe 9.3.3. Asia Pacific 9.3.4. Latin America 9.3.5. Middle East & Africa 9.4. Global Market Analysis, by Region 9.5. Global Market Attractiveness Analysis, by Region 10. North America Market Analysis 10.1. North America Market Key Findings 10.2. North America Market Overview 10.3. North America Market Size and Forecast, by Test Type 10.3.1. Prenatal Testing Services 10.3.2. New Born Screening 10.3.3. Predictive and Presymptomatic Testing 10.3.4. Pharmacogenomic Testing 10.3.5. Others 10.3.6. North America Market Analysis, by Test Type 10.4. North America Market Size and Forecast, by Service Providers 10.4.1. Hospital Based Laboratories 10.4.2. Diagnostic laboratories 10.4.3. Specialty Clinics 10.4.4. Others 10.5. North America Market Forecast, by Applications 10.5.1. Oncology 10.5.2. Infectious Diseases 10.5.3. Autoimmune Diseases 10.5.4. Others 10.6. North America Market Forecast, by Country 10.6.1. U.S. 10.6.2. Canada 10.7. North America Market Attractiveness Analysis 10.7.1. By Test Type 10.7.2. By Service Providers 10.7.3. By Applications 10.7.4. By Country 11. Europe Market Analysis 11.1. Europe Market Key Findings 11.2. Europe Market Overview 11.3. Europe Market Size and Forecast, by Test Type 11.3.1. Prenatal Testing Services 11.3.2. New Born Screening 11.3.3. Predictive and Presymptomatic Testing 11.3.4. Pharmacogenomic Testing 11.3.5. Others 11.4. Europe Market Size and Forecast, by Service Providers 11.4.1. Hospital Based Laboratories 11.4.2. Diagnostic laboratories 11.4.3. Specialty Clinics 11.4.4. Others 11.5. Europe Market Forecast, by Applications 11.5.1. Oncology 11.5.2. Infectious Diseases 11.5.3. Autoimmune Diseases 11.5.4. Others 11.6. Europe Market Forecast, by Country 11.6.1. Germany 11.6.2. U.K. 11.6.3. France 11.6.4. Spain 11.6.5. Italy 11.6.6. Rest of Europe 11.7. Europe Market Attractiveness Analysis 11.7.1. By Test Type 11.7.2. By Service Providers 11.7.3. By Applications 11.7.4. By Country 12. Asia Pacific Market Analysis 12.1. Asia Pacific Market Key Findings 12.2. Asia Pacific Market Overview 12.3. Asia Pacific Cytometry Market Size and Forecast, by Test Type 12.3.1. Prenatal Testing Services 12.3.2. New Born Screening 12.3.3. Predictive and Presymptomatic Testing 12.3.4. Pharmacogenomic Testing 12.3.5. Others 12.4. Asia Pacific Market Size and Forecast, by Service Providers 12.4.1. Hospital Based Laboratories 12.4.2. Diagnostic laboratories 12.4.3. Specialty Clinics 12.4.4. Others 12.5. Asia Pacific Market Forecast, by Applications 12.5.1. Oncology 12.5.2. Infectious Diseases 12.5.3. Autoimmune Diseases 12.5.4. Others 12.6. Asia Pacific Market Forecast, by Country 12.6.1. China 12.6.2. India 12.6.3. Japan 12.6.4. Australia & New Zealand 12.6.5. Rest of Asia Pacific 12.7. Asia Pacific Market Attractiveness Analysis 12.7.1. By Test Type 12.7.2. By Service Providers 12.7.3. By Applications 12.7.4. By Country 13. Latin America Market Analysis 13.1. Latin America Market Key Findings 13.2. Latin America Market Overview 13.3. Latin America Cytometry Market Size and Forecast, by Test Type 13.3.1. Prenatal Testing Services 13.3.2. New Born Screening 13.3.3. Predictive and Presymptomatic Testing 13.3.4. Pharmacogenomic Testing 13.3.5. Others 13.4. Latin America Market Size and Forecast, by Service Providers 13.4.1. Hospital Based Laboratories 13.4.2. Diagnostic laboratories 13.4.3. Specialty Clinics 13.4.4. Others 13.5. Latin America Market Forecast, by Country 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Latin America Market Forecast, by Applications 13.6.1. Oncology 13.6.2. Infectious Diseases 13.6.3. Autoimmune Diseases 13.6.4. Others 13.7. Latin America Market Attractiveness Analysis 13.7.1. By Test Type 13.7.2. By Service Providers 13.7.3. By Applications 13.7.4. By Country 14. Middle East & Africa Market Analysis 14.1. Middle East & Africa Market Key Findings 14.2. Middle East & Africa Market Overview 14.3. Middle East & Africa Cytometry Market Size and Forecast, by Test Type 14.3.1. Prenatal Testing Services 14.3.2. New Born Screening 14.3.3. Predictive and Presymptomatic Testing 14.3.4. Pharmacogenomic Testing 14.3.5. Others 14.4. Middle East & Africa Market Size and Forecast, by Service Providers 14.4.1. Hospital Based Laboratories 14.4.2. Diagnostic laboratories 14.4.3. Specialty Clinics 14.4.4. Others 14.5. Middle East & Africa Market Forecast, by Applications 14.5.1. Oncology 14.5.2. Infectious Diseases 14.5.3. Autoimmune Diseases 14.5.4. Others 14.6. Middle East & Africa Market Size and Forecast, by Country 14.6.1. GCC Countries 14.6.2. Israel 14.6.3. South Africa 14.6.4. Rest of Middle East & Africa 14.7. Middle East Market Attractiveness Analysis 14.7.1. By Test Type 14.7.2. By Service Providers 14.7.3. By Applications 14.7.4. By Country 15. Competition Landscape 15.1. Global Market Share Analysis, by Company (2022) 15.2. Company Profiles 15.2.1. Laboratory Corporation of America Holdings 15.2.1.1. Overview (HQ, Employee Strength, Business Segments) 15.2.1.2. Financials 15.2.1.3. Recent Developments 15.2.1.4. Strategy 15.2.2. Quest Diagnostics Incorporated 15.2.2.1. Overview (HQ, Employee Strength, Business Segments) 15.2.2.2. Financials 15.2.2.3. Recent Developments 15.2.2.4. Strategy 15.2.3. Genomic Health, Inc. 15.2.3.1. Overview (HQ, Employee Strength, Business Segments) 15.2.3.2. Financials 15.2.3.3. Recent Developments 15.2.3.4. Strategy 15.2.4. NeoGenomics Laboratories, Inc. 15.2.4.1. Overview (HQ, Employee Strength, Business Segments) 15.2.4.2. Financials 15.2.4.3. Recent Developments 15.2.4.4. Strategy 15.2.5. Eurofins Scientific 15.2.5.1. Overview (HQ, Employee Strength, Business Segments) 15.2.5.2. Financials 15.2.5.3. Recent Developments 15.2.5.4. Strategy 15.2.6. Ambry Genetics 15.2.6.1. Overview (HQ, Employee Strength, Business Segments) 15.2.6.2. Financials 15.2.6.3. Recent Developments 15.2.6.4. Strategy 15.2.7. F. Hoffmann-La Roche Ltd 15.2.7.1. Overview (HQ, Employee Strength, Business Segments) 15.2.7.2. Financials 15.2.7.3. Recent Developments 15.2.7.4. Strategy 15.2.8. Illumina, Inc 15.2.8.1. Overview (HQ, Employee Strength, Business Segments) 15.2.8.2. Financials 15.2.8.3. Recent Developments 15.2.8.4. Strategy 15.2.9. CENTOGENE AG 15.2.9.1. Overview (HQ, Employee Strength, Business Segments) 15.2.9.2. Financials 15.2.9.3. Recent Developments 15.2.9.4. Strategy 15.2.10. 23andMe, Inc. 15.2.10.1. Overview (HQ, Employee Strength, Business Segments) 15.2.10.2. Financials 15.2.10.3. Recent Developments 15.2.10.4. Strategy
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 02: Global Market Value (US$ Mn) Forecast, by Service Provider, 2023–2033
Table 03: Global Market Value (US$ Mn) Forecast, by Applications, 2023–2033
Table 04: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
Table 05: North America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 06: North America Market Value (US$ Mn) Forecast, by Service Providers,
Table 07: North America Market Value (US$ Mn) Forecast, by Applications,
Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 09: Europe Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 10: Europe Market Value (US$ Mn) Forecast, by Service Providers,
Table 11: Europe Market Value (US$ Mn) Forecast, by Applications,
Table 12: Europe Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 13: Asia Pacific Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Service Providers,
Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Applications,
Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 17: Latin America Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 18: Latin America Market Value (US$ Mn) Forecast, by Service Providers,
Table 19: Latin America Market Value (US$ Mn) Forecast, by Applications,
Table 20: Latin America Market Value (US$ Mn) Forecast, by Country, 2023–2033
Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Test Type, 2023–2033
Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Providers,
Table 23: Middle East & Africa Market Value (US$ Mn) Forecast, by Service Applications
Table 24: Middle East & Africa Market Value (US$ Mn) Forecast, by Country, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Genetic Testing Services, by Test Type, Market Size (US$ Mn), 2022 (A)
Figure 02: Global Market Revenue (%), by Service Providers, 2022 (A)
Figure 03: Distribution of Market by Region, 2023 and 2033
Figure 04: Key Industry Developments
Figure 05: Global Market Size (US$ Mn) Forecast, 2023–2033
Figure 06: Porter’s Five Forces Analysis
Figure 07: Global Market Value Share, by Test Type (2022)
Figure 08: Global Market Value Share, by Service Providers (2022)
Figure 09: Global Market Value Share, by Applications (2022)
Figure 10: Global Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prenatal Testing, 2023–2033
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by New Born Screening
Figure 13: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Predictive and Presymptomatic Testing, 2023–2033
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Human and Tumor Genetics, 2023–2033
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other, 2023–2033
Figure 16: Global Market Attractiveness Analysis, by Test Type
Figure 17: Global Market Value Share Analysis, by Service Provider, 2023 and 2033
Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Based Laboratories, 2023–2033
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2023–2033
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2023–2033
Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033
Figure 22: Global Market Attractiveness Analysis, by Service Provider
Figure 23: Global Market Value Share Analysis, by Applications, 2023 and 2033
Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oncology, 2023–2033
Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Infectious Disease, 2023–2033
Figure 26: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Autoimmune Disease, 2023–2033
Figure 27: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2023–2033
Figure 28: Global Market Attractiveness Analysis, by Applications
Figure 29: Global Market Scenario
Figure 30: Global Market Value Share Analysis, by Region, 2023 and 2033
Figure 31: Global Market Attractiveness Analysis, by Region
Figure 32: North America Market Size (US$ Mn) Forecast, 2023–2033
Figure 33: North America Market Attractiveness Analysis,
Figure 34: North America Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 35: North America Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 36: North America Market Value Share Analysis, by Applications, 2023 and 2033
Figure 37: North America Market Value Share Analysis, by Country, 2023 and 2033
Figure 38: North America Market Attractiveness Analysis, by Test types, 2023–2033
Figure 39: North America Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 40: North America Market Attractiveness Analysis, by Applications, 2023–2033
Figure 41: Europe Market Size (US$ Mn) Forecast, 2023–2033
Figure 42: Europe Market Attractiveness Analysis,
Figure 43: Europe Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 44: Europe Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 45: Europe Market Value Share Analysis, by Applications, 2023 and 2033
Figure 46: Europe Market Value Share Analysis, by Country, 2023 and 2033
Figure 47: Europe Market Attractiveness Analysis, by Test types, 2023–2033
Figure 48: Europe Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 49: Europe Market Attractiveness Analysis, by Applications, 2023–2033
Figure 50: Asia Pacific Market Size (US$ Mn) Forecast, 2023–2033
Figure 51: Asia Pacific Market Attractiveness Analysis,
Figure 52: Asia Pacific Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 53: Asia Pacific Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 54: Asia Pacific Market Value Share Analysis, by Applications, 2023 and 2033
Figure 55: Asia Pacific Market Value Share Analysis, by Country, 2023 and 2033
Figure 56: Asia Pacific Market Attractiveness Analysis, by Test types, 2023–2033
Figure 57: Asia Pacific Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 58: Asia Pacific Market Attractiveness Analysis, by Applications, 2023–2033
Figure 59: Latin America Market Size (US$ Mn) Forecast, 2023–2033
Figure 60: Latin America Market Attractiveness Analysis,
Figure 61: Latin America Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 62: Latin America Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 63: Latin America Market Value Share Analysis, by Applications, 2023 and 2033
Figure 64: Latin America Market Value Share Analysis, by Country, 2023 and 2033
Figure 65: Latin America Market Attractiveness Analysis, by Test types, 2023–2033
Figure 66: Latin America Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 67: Latin America Market Attractiveness Analysis, by Applications, 2023–2033
Figure 68: Middle East & Africa Market Size (US$ Mn) Forecast, 2023–2033
Figure 69: Middle East & Africa Market Attractiveness Analysis,
Figure 70: Middle East & Africa Market Value Share Analysis, by Test Type, 2023 and 2033
Figure 71: Middle East & Africa Market Value Share Analysis, by Service Providers, 2023 and 2033
Figure 72: Middle East & Africa Market Value Share Analysis, by Applications, 2023 and 2033
Figure 73: Middle East & Africa Market Value Share Analysis, by Country, 2023 and 2033
Figure 74: Middle East & Africa Market Attractiveness Analysis, by Test types, 2023–2033
Figure 75: Middle East & Africa Market Attractiveness Analysis, by Service Providers, 2023–2033
Figure 76: Middle East & Africa Market Attractiveness Analysis, by Applications, 2023–2033
Figure 77: Laboratory Corporation of America Holdings. Revenue (US$ Bn) and Y-o-Y Growth (%), 2022–2022
Figure 78: Laboratory Corporation of America Holdings. Net Sales, By Geography, 2022
Figure 79: Laboratory Corporation of America Holdings. Breakdown of Net Sales, By Segment, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the current genetic testing services market size?
Global genetic testing service demand is valued at US$ 3,956 million in 2023.
What is the predicted growth rate for the genetic testing services market?
Adoption of genetic testing services is forecasted to increase at a CAGR of 8.5% through 2033.
What is boosting the demand for genetic testing services?
Favorable government initiatives for promoting genetic testing and increasing prevalence of genetic disorders are boosting market revenue growth.
Which is the most dominant regional market for genetic testing services?
North America accounts for 40% share of the global genetic testing services market.
What is the predicted size of the genetic testing services market?
The global genetic testing services market is estimated to reach US$ 8,944.4 million by 2033.
Genetic Testing Services Market